Skip to Content

Cipla 516 25 mg (Cyclophosphamide 25 mg)

Pill with imprint Cipla 516 25 mg is Blue & White, Capsule-shape and has been identified as Cyclophosphamide 25 mg. It is supplied by Cipla USA Inc..

Cyclophosphamide is used in the treatment of acute lymphocytic leukemia; breast cancer; acute nonlymphocytic leukemia; cancer; chronic lymphocytic leukemia and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Cyclophosphamide 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Cipla 516 25 mg

Cyclophosphamide 25 mg Cipla 516 25 mg

Cyclophosphamide

Imprint
Cipla 516 25 mg
Strength
25 mg
Color
Blue & White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Alkylating agents
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla USA Inc.
National Drug Code (NDC)
69097-0516

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.